Semaglutide Injection 2.5mg/1.5ml PFS Manufacturer

Product Overview

Sanjar Pharma manufactures Semaglutide Injection 2.5mg/1.5ml in a prefilled syringe format at its WHO-GMP compliant sterile injectable manufacturing facility. The product is manufactured under controlled pharmaceutical conditions using validated production processes, advanced quality systems, and stringent environmental controls.

Semaglutide is a GLP-1 Receptor Agonist and forms part of a rapidly expanding category of specialty injectable pharmaceutical products. The prefilled syringe presentation supports administration convenience, dosing precision, and efficient product handling across healthcare environments.

Supported by dedicated sterile manufacturing infrastructure, analytical testing laboratories, microbiology facilities, and quality assurance systems, Sanjar Pharma supplies Semaglutide Injection to pharmaceutical companies, healthcare providers, distributors, procurement organizations, and international pharmaceutical markets.